General Surgery

Mersey, United Kingdom

General Surgery

Mersey, United Kingdom
SEARCH FILTERS
Time filter
Source Type

Sarasota, FL, May 22, 2017 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Biomaterials Market (Cardiovascular Biomaterials, Orthopedic Biomaterials, Wound Care Biomaterials, Urological Biomaterials Plastic Surgery Biomaterials, and Gastrointestinal Biomaterials)  by Materials (Ceramics, Metals and Polymers) for Drug Delivery, Dental Products, Surgical Appliances & Supplies, General Surgery, Electromedical Equipment and Other Applications: Brazil Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022”. According to the report, demand for Brazil biomaterials market in was valued at over USD1.89 billion in 2016, is expected to reach above USD 5.18 billion in 2022 and is anticipated to grow at a CAGR of slightly above 18.30% between 2017 and 2022. Biomaterials are synthetic, natural, solid or liquid, which are mainly used in medical devices, biological systems. In recent times, biomaterials are also used to grow cells in culture, processing biomolecular in biotechnology, bio-inert to assay for blood proteins in the clinical laboratory, for fertility regulation implants in cattle, in diagnostic gene arrays. Biomaterials are also used in the aquaculture of oysters and for investigational cell-silicon "biochips." Browse through 6 Market Tables and 22 Figures spread through 110 Pages and in-depth TOC on “Brazil Biomaterials Market: By Type, Product, Material, Application, Size, Share, Growth, Analysis, Segment and Forecast 2016 – 2022”. Rising prevalence of diverse diseases has led to huge growth in the healthcare sector. This factor is expected to fuel the growth of the biomaterials market in the coming years. Growing aging population in Brazil is likely to positively impact on the growth of the biomaterials market in the forecast period. Biomaterials are used in various applications such as contact lens, dental, gene transfer, skin repair and in drug delivery system among others. This factor may stimulate the biomaterial market growth in the upcoming years. Hectic lifestyle along with increasing demand for western food has led to high cardiovascular diseases. Hence, rising cardiovascular disease may trigger the growth of the biomaterials market in the forecast period. Nevertheless, ongoing research for debio-inert materials may provide ample opportunities to the biomaterials market in the forecast period. Moreover, tremendously expanding healthcare sector in Brazil and growing medical tourism may foster the market in the coming years. The biomaterials market can be segmented into products which include cardiovascular biomaterials, orthopedic biomaterials, wound care biomaterials, urological biomaterials plastic surgery biomaterials and gastrointestinal biomaterials. Cardiovascular biomaterials can be further sub-segmented into vascular access devices, cardiac stents, artificial heart valves, peripheral vascular grafts, cardiac pacemakers and implantable cardioverter defibrillators. Orthopedic biomaterials consist of implantable cardioverter defibrillators, trauma orthopedic biomaterials, trauma orthopedic biomaterials, bone cement, ortho biologics biomaterials, and reconstructive biomaterials. Orthopedic biomaterials comprise high product penetration. Therefore, orthopedic biomaterials will specter huge demand in the coming years. Moreover, owing to unhealthy lifestyle there has been tremendous growth in the cardiovascular diseases which has led to the high usage of cardiovascular biomaterials. The materials mainly used in biomaterials are ceramics, metals, and polymers. Biomaterials possess diverse applications, some of which includes drug delivery, dental products, surgical appliances & supplies, general surgery, electromedical equipment and other applications. Browse the full "Biomaterials Market (Cardiovascular Biomaterials, Orthopedic Biomaterials, Wound Care Biomaterials, Urological Biomaterials Plastic Surgery Biomaterials and Gastrointestinal Biomaterials)  by Materials (Ceramics, Metals and Polymers) for Drug Delivery, Dental Products, Surgical Appliances & Supplies, General Surgery, Electromedical Equipment and Other Applications: Brazil Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022" report at https://www.zionmarketresearch.com/report/biomaterials-market There has been the sharp rise in the healthcare industry in Brazil owing to low healthcare cost. Brazil stands as the fifth largest country area wise and in population. The healthcare sector has undergone rapid transformation owing to the new business paradigm in Brazilian healthcare market. This factor is expected to trigger the growth of biomaterials market in this region in the upcoming years. An increasing number of life expectancy among the aging population may boost the biomaterials market in the forecast period. Moreover, Brazil is considered as the most favorable destination for medical tourism owing to its superior medical facilities, high-quality services, and low cost for treatment. This aspect is likely to bolster the growth of the biomaterial market. Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/biomaterials-market Allergan Inc., Artimplant Ab, Alphatec Spine Inc, Biomet Inc., Synthes Inc., Integra Life Sciences Holdings Corporation, Wright Medical Group, Inc., Stryker Corporation, Baxter International Inc. and Boston Scientific Corporation are some of the major players operating in the biomaterials market in Brazil. Due to various favorable government regulations many of the major companies are pulling towards Brazil. This report segments Brazil biomaterials market as follows: Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.


News Article | April 20, 2017
Site: www.eurekalert.org

Medical complications of brown recluse spider bites are uncommon but they can be severe, particularly in children, researchers at Vanderbilt University Medical Center (VUMC) reported today. The hallmark sign of a brown recluse spider bite is a painful, blistering skin lesion. In rare cases the bite also can cause a severe illness called systemic loxoscelism, characterized by a blood clotting disorder and hemolysis, destruction of red blood cells. Patients presenting with these symptoms often don't know they were bitten. But loxoscelism should be suspected, particularly if patients live in parts of the Southeast and Midwest where the spiders thrive and especially if they are children, the researchers concluded. "Children are much more likely to develop this systemic syndrome," said Vanderbilt hematologist Jeremy Warner, M.D., M.S., senior author of the report published in PLOS ONE, a journal of the Public Library of Science. In severe cases, treatment may require hospitalization, blood transfusions and other supportive measures. African-Americans also may be at higher risk, said Warner, assistant professor of Medicine and Biomedical Informatics in the Vanderbilt University School of Medicine. "We were inspired to carry out this analysis after treating a patient with a particularly striking episode of hemolysis several days after a brown recluse spider bite," he said. "He lost literally half of his blood supply over the course of 24 hours but was ultimately OK." Warner, who is from New England, had never seen a case of systemic loxoscelism before. The vulnerability of children to the venom of the brown recluse spider was picked up during a review of more than 2.4 million patient records stored electronically at VUMC between 1995 and 2015 and de-linked from personal identifying information. Called the Synthetic Derivative, the vast database allows researchers to search for phenotypes - clinical descriptions, lab measures, demographic and environmental characteristics -- that are common to patients with the same diagnosis. Led by first author Jamie Robinson, M.D., a General Surgery resident and post-graduate fellow in Biomedical Informatics, the researchers used this approach to identify 57 patients -- the largest cohort of individuals with moderate to severe loxoscelism ever reported. Only a third of the patients knew they'd been bitten. It may be possible to use phenotypes to pick out patients who don't know they've been bitten and have not been formally diagnosed. In this way, Warner said, the study advances the goal of personalized medicine, to diagnose conditions earlier and provide the most effective treatment based on patients' genetic and phenotypic characteristics. Contributing to the study was Joshua Denny, M.D., M.S., professor of Biomedical Informatics and director of the Data and Research Support Center of the National Institutes of Health All of Us Research Program, formerly known as the Precision Medicine Initiative Cohort Program. Other co-authors were Vanessa Kennedy, M.D., Youssef Doss and Lisa Bastarache.


Global Breast Imaging Market Shows Positive Signs of Growth During the Forecast Period 2017-2022 Breast imaging is the screening of the breast to detect cancer at various levels. The report highlights a significant growth for the market at a positive CAGR during the forecast period 2017-2022. Albany, NY, May 06, 2017 --( Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1037516 Breast imaging is the screening of the breast to detect cancer at various levels. Breast cancer is a major type of cancer which is the cause of a mass death percentage; therefore, its early detection and effective medication need to be done with proper awareness to eradicate the problem. Breast imaging may range from Mammography, Tomosynthesis, Xeromammography, Galactography, Breast MRI, Breast ultrasound and others. The report starts with the overview of breast imaging market detailing product overview and its scope. The report further segments the market by breast imaging types such as analog breast imaging equipment and digital breast imaging equipment, providing comparison analysis of their production, CAGR and market share. Breast imaging application is also reported with their consumption comparison for the period 2012-2022. The applications listed include- General Surgery, Breast Surgery, and Physical examination. On the geographical scale, global breast imaging market is compared for market status and prospect for 2012-2022. The regions compared in the report include North America, Europe, China, Japan, Southeast Asia and India. Further, the breast imaging market competition is reported on the global scale for 2012-2017, along with its concentration rate, mergers & acquisitions, and expansion. Top players in the field include: · GE Healthcare · Siemens · Hologic · Philips Healthcare · Toshiba · Dilon Technologies · Gamma Medica · Sonocine · Fujifilm · Aurora Imaging Technology Further, a detailed comparison analysis is done to display supply, consumption, export, import by region; production, revenue, price trend by type and lastly market share, growth rate, market drivers & opportunities by the application. Browse Full Report with TOC: http://www.marketresearchhub.com/report/global-breast-imaging-market-research-report-2017-report.html The report concludes by offering breast imaging manufacturing cost analysis covering key raw material, price trend and proportion of manufacturing cost structure. Moreover, details of raw material, labor cost and manufacturing expenses can also be analyzed. The reader can also learn about the future consequences that may affect the market growth. These are mentioned under market effect factors analysis that constitutes technology risk, consumer preference change and environmental/political environmental change. About Market Research Hub: Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps. MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients. Contact Details: 90 State Street, Albany, NY 12207, United States Toll Free: 866-997-4948 (US-Canada) Tel: +1-518-621-2074 Email: press@marketresearchhub.com Website: http://www.marketresearchhub.com/ Follow Us on: Twitter: https://twitter.com/MktResearchHub/ LinkedIn: https://www.linkedin.com/company/market-research-hub/ Facebook: https://www.facebook.com/MarketResearchHub/ Albany, NY, May 06, 2017 --( PR.com )-- The surging unhealthy lifestyle of the young generation and effects of adulteration, have led to the rising number of breast cancer problems at the global level. To give detailed insight and forecasted growth of the breast imaging market, Market Research Hub (MRH) has added a report titled “Global Breast Imaging Market Research Report 2017” to its wide database. The report highlights a significant growth for the market at a positive CAGR during the forecast period 2017-2022.Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1037516Breast imaging is the screening of the breast to detect cancer at various levels. Breast cancer is a major type of cancer which is the cause of a mass death percentage; therefore, its early detection and effective medication need to be done with proper awareness to eradicate the problem. Breast imaging may range from Mammography, Tomosynthesis, Xeromammography, Galactography, Breast MRI, Breast ultrasound and others.The report starts with the overview of breast imaging market detailing product overview and its scope. The report further segments the market by breast imaging types such as analog breast imaging equipment and digital breast imaging equipment, providing comparison analysis of their production, CAGR and market share. Breast imaging application is also reported with their consumption comparison for the period 2012-2022. The applications listed include- General Surgery, Breast Surgery, and Physical examination.On the geographical scale, global breast imaging market is compared for market status and prospect for 2012-2022. The regions compared in the report include North America, Europe, China, Japan, Southeast Asia and India. Further, the breast imaging market competition is reported on the global scale for 2012-2017, along with its concentration rate, mergers & acquisitions, and expansion. Top players in the field include:· GE Healthcare· Siemens· Hologic· Philips Healthcare· Toshiba· Dilon Technologies· Gamma Medica· Sonocine· Fujifilm· Aurora Imaging TechnologyFurther, a detailed comparison analysis is done to display supply, consumption, export, import by region; production, revenue, price trend by type and lastly market share, growth rate, market drivers & opportunities by the application.Browse Full Report with TOC: http://www.marketresearchhub.com/report/global-breast-imaging-market-research-report-2017-report.htmlThe report concludes by offering breast imaging manufacturing cost analysis covering key raw material, price trend and proportion of manufacturing cost structure. Moreover, details of raw material, labor cost and manufacturing expenses can also be analyzed. The reader can also learn about the future consequences that may affect the market growth. These are mentioned under market effect factors analysis that constitutes technology risk, consumer preference change and environmental/political environmental change.About Market Research Hub:Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.Contact Details:90 State Street,Albany, NY 12207,United StatesToll Free: 866-997-4948 (US-Canada)Tel: +1-518-621-2074Email: press@marketresearchhub.comWebsite: http://www.marketresearchhub.com/Follow Us on:Twitter: https://twitter.com/MktResearchHub/LinkedIn: https://www.linkedin.com/company/market-research-hub/Facebook: https://www.facebook.com/MarketResearchHub/ Click here to view the list of recent Press Releases from Market Research Hub


News Article | May 22, 2017
Site: www.businesswire.com

MAYSVILLE, Ky.--(BUSINESS WIRE)--Meadowview Regional Medical Center today announced that it has been named a Duke LifePoint Quality Affiliate. This designation recognizes hospitals within the LifePoint Health system that have enrolled in the LifePoint National Quality Program and succeeded in transforming their culture of safety and achieving high standards of quality care, performance improvement and patient engagement. “Meadowview Regional Medical Center has a long legacy of providing high quality care, and earning this esteemed designation is just one more way the hospital is making the Maysville community healthier,” said Joe Koch, chief executive officer of Meadowview Regional Medical Center. “I am so proud to be part of the Meadowview team and look forward to continuing the hospital’s great work to improve patient care, safety and satisfaction long into the future.” Meadowview Regional Medical Center is a 100-bed, acute-care facility serving people in the Maysville, Ky., community and surrounding areas. To achieve Duke LifePoint Quality Affiliate designation, the Meadowview team worked to implement a number of best practices and launch new initiatives to engage patients and families, enhance patient safety and improve quality care. For example, the hospital initiated leadership safety briefings each morning to ensure that leaders have a regular proactive planning session to address patient concerns. The hospital also implemented bedside shift reporting to help ensure clear communication, reduce the risk of errors and maintain consistency of care during shift changes. Bedside shift reporting is an effective method for transferring information from one provider to another, while also involving the patient in discussions about their health, progress and treatment plan. Additionally, Meadowview established a Community Collaborative in an effort to work closely with other healthcare providers and organizations in the community to help reduce avoidable patient readmissions. “At LifePoint, quality is truly at the core of our culture and operations, and Meadowview has gone above and beyond to satisfy the rigorous requirements necessary to be named a Duke LifePoint Quality Affiliate,” said David Dill, president and chief operating officer of LifePoint Health. “We are delighted to recognize this high-performing facility and commend the many improvements it has made to take even better care of patients and their families.” The LifePoint National Quality Program was created through a collaboration between LifePoint Health and Duke University Health System. When hospitals enroll in the program, they begin working with Duke and LifePoint quality coaches to evaluate and strengthen their quality programs and processes. Following an initial evaluation, the hospital creates a plan and begins to deploy changes that will help it achieve quality improvement benchmarks and establish long-term solutions to sustain its results. In addition to evaluating common quality care and patient safety metrics, the LifePoint National Quality Program focuses on foundational elements required to sustain quality care, including committed leadership, systems to ensure continuous performance and process improvement, and a culture dedicated to safety. Duke LifePoint Quality Affiliate designation denotes those hospitals that achieve a broad range of criteria in each of these areas and demonstrate a capacity to continuously measure and improve quality and patient safety. MRMC is a 100-bed acute care facility located along the Ohio River in Maysville, Kentucky. The service area consists of five counties in Kentucky and two counties in Ohio. Delivering quality healthcare close to home is the single most important contribution we make in achieving our mission of Making Communities Healthier®. Our medical staff consists of well-trained physicians covering a number of specialties, including Allergy, Anesthesia, Cardiology, Emergency Medicine, Endocrinology, Family Practice, Gastroenterology, General Surgery, Hematology/Oncology, Hospitalist, Internal Medicine, Nephrology, Neurology, Obstetrics/Gynecology, Ophthalmology, Orthopedics, Otolaryngology, Pathology, Pediatrics, Podiatry, Radiation Therapy, Radiology, Sleep Medicine and Urology. For more information, visit www.MeadowviewRegional.com. LifePoint Health (NASDAQ: LPNT) is a leading healthcare company dedicated to Making Communities Healthier®. Through its subsidiaries, it provides quality inpatient, outpatient and post-acute services close to home. LifePoint owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in 22 states. It is the sole community healthcare provider in the majority of the non-urban communities it serves. More information about the company can be found at www.LifePointHealth.net.


Sarasota, FL, May 22, 2017 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Biomaterials Market (Cardiovascular Biomaterials, Orthopedic Biomaterials, Wound Care Biomaterials, Urological Biomaterials Plastic Surgery Biomaterials, and Gastrointestinal Biomaterials)  by Materials (Ceramics, Metals and Polymers) for Drug Delivery, Dental Products, Surgical Appliances & Supplies, General Surgery, Electromedical Equipment and Other Applications: Brazil Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022”. According to the report, demand for Brazil biomaterials market in was valued at over USD1.89 billion in 2016, is expected to reach above USD 5.18 billion in 2022 and is anticipated to grow at a CAGR of slightly above 18.30% between 2017 and 2022. Biomaterials are synthetic, natural, solid or liquid, which are mainly used in medical devices, biological systems. In recent times, biomaterials are also used to grow cells in culture, processing biomolecular in biotechnology, bio-inert to assay for blood proteins in the clinical laboratory, for fertility regulation implants in cattle, in diagnostic gene arrays. Biomaterials are also used in the aquaculture of oysters and for investigational cell-silicon "biochips." Browse through 6 Market Tables and 22 Figures spread through 110 Pages and in-depth TOC on “Brazil Biomaterials Market: By Type, Product, Material, Application, Size, Share, Growth, Analysis, Segment and Forecast 2016 – 2022”. Rising prevalence of diverse diseases has led to huge growth in the healthcare sector. This factor is expected to fuel the growth of the biomaterials market in the coming years. Growing aging population in Brazil is likely to positively impact on the growth of the biomaterials market in the forecast period. Biomaterials are used in various applications such as contact lens, dental, gene transfer, skin repair and in drug delivery system among others. This factor may stimulate the biomaterial market growth in the upcoming years. Hectic lifestyle along with increasing demand for western food has led to high cardiovascular diseases. Hence, rising cardiovascular disease may trigger the growth of the biomaterials market in the forecast period. Nevertheless, ongoing research for debio-inert materials may provide ample opportunities to the biomaterials market in the forecast period. Moreover, tremendously expanding healthcare sector in Brazil and growing medical tourism may foster the market in the coming years. The biomaterials market can be segmented into products which include cardiovascular biomaterials, orthopedic biomaterials, wound care biomaterials, urological biomaterials plastic surgery biomaterials and gastrointestinal biomaterials. Cardiovascular biomaterials can be further sub-segmented into vascular access devices, cardiac stents, artificial heart valves, peripheral vascular grafts, cardiac pacemakers and implantable cardioverter defibrillators. Orthopedic biomaterials consist of implantable cardioverter defibrillators, trauma orthopedic biomaterials, trauma orthopedic biomaterials, bone cement, ortho biologics biomaterials, and reconstructive biomaterials. Orthopedic biomaterials comprise high product penetration. Therefore, orthopedic biomaterials will specter huge demand in the coming years. Moreover, owing to unhealthy lifestyle there has been tremendous growth in the cardiovascular diseases which has led to the high usage of cardiovascular biomaterials. The materials mainly used in biomaterials are ceramics, metals, and polymers. Biomaterials possess diverse applications, some of which includes drug delivery, dental products, surgical appliances & supplies, general surgery, electromedical equipment and other applications. Browse the full "Biomaterials Market (Cardiovascular Biomaterials, Orthopedic Biomaterials, Wound Care Biomaterials, Urological Biomaterials Plastic Surgery Biomaterials and Gastrointestinal Biomaterials)  by Materials (Ceramics, Metals and Polymers) for Drug Delivery, Dental Products, Surgical Appliances & Supplies, General Surgery, Electromedical Equipment and Other Applications: Brazil Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022" report at https://www.zionmarketresearch.com/report/biomaterials-market There has been the sharp rise in the healthcare industry in Brazil owing to low healthcare cost. Brazil stands as the fifth largest country area wise and in population. The healthcare sector has undergone rapid transformation owing to the new business paradigm in Brazilian healthcare market. This factor is expected to trigger the growth of biomaterials market in this region in the upcoming years. An increasing number of life expectancy among the aging population may boost the biomaterials market in the forecast period. Moreover, Brazil is considered as the most favorable destination for medical tourism owing to its superior medical facilities, high-quality services, and low cost for treatment. This aspect is likely to bolster the growth of the biomaterial market. Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/biomaterials-market Allergan Inc., Artimplant Ab, Alphatec Spine Inc, Biomet Inc., Synthes Inc., Integra Life Sciences Holdings Corporation, Wright Medical Group, Inc., Stryker Corporation, Baxter International Inc. and Boston Scientific Corporation are some of the major players operating in the biomaterials market in Brazil. Due to various favorable government regulations many of the major companies are pulling towards Brazil. This report segments Brazil biomaterials market as follows: Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.


Sarasota, FL, May 22, 2017 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Biomaterials Market (Cardiovascular Biomaterials, Orthopedic Biomaterials, Wound Care Biomaterials, Urological Biomaterials Plastic Surgery Biomaterials, and Gastrointestinal Biomaterials)  by Materials (Ceramics, Metals and Polymers) for Drug Delivery, Dental Products, Surgical Appliances & Supplies, General Surgery, Electromedical Equipment and Other Applications: Brazil Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022”. According to the report, demand for Brazil biomaterials market in was valued at over USD1.89 billion in 2016, is expected to reach above USD 5.18 billion in 2022 and is anticipated to grow at a CAGR of slightly above 18.30% between 2017 and 2022. Biomaterials are synthetic, natural, solid or liquid, which are mainly used in medical devices, biological systems. In recent times, biomaterials are also used to grow cells in culture, processing biomolecular in biotechnology, bio-inert to assay for blood proteins in the clinical laboratory, for fertility regulation implants in cattle, in diagnostic gene arrays. Biomaterials are also used in the aquaculture of oysters and for investigational cell-silicon "biochips." Browse through 6 Market Tables and 22 Figures spread through 110 Pages and in-depth TOC on “Brazil Biomaterials Market: By Type, Product, Material, Application, Size, Share, Growth, Analysis, Segment and Forecast 2016 – 2022”. Rising prevalence of diverse diseases has led to huge growth in the healthcare sector. This factor is expected to fuel the growth of the biomaterials market in the coming years. Growing aging population in Brazil is likely to positively impact on the growth of the biomaterials market in the forecast period. Biomaterials are used in various applications such as contact lens, dental, gene transfer, skin repair and in drug delivery system among others. This factor may stimulate the biomaterial market growth in the upcoming years. Hectic lifestyle along with increasing demand for western food has led to high cardiovascular diseases. Hence, rising cardiovascular disease may trigger the growth of the biomaterials market in the forecast period. Nevertheless, ongoing research for debio-inert materials may provide ample opportunities to the biomaterials market in the forecast period. Moreover, tremendously expanding healthcare sector in Brazil and growing medical tourism may foster the market in the coming years. The biomaterials market can be segmented into products which include cardiovascular biomaterials, orthopedic biomaterials, wound care biomaterials, urological biomaterials plastic surgery biomaterials and gastrointestinal biomaterials. Cardiovascular biomaterials can be further sub-segmented into vascular access devices, cardiac stents, artificial heart valves, peripheral vascular grafts, cardiac pacemakers and implantable cardioverter defibrillators. Orthopedic biomaterials consist of implantable cardioverter defibrillators, trauma orthopedic biomaterials, trauma orthopedic biomaterials, bone cement, ortho biologics biomaterials, and reconstructive biomaterials. Orthopedic biomaterials comprise high product penetration. Therefore, orthopedic biomaterials will specter huge demand in the coming years. Moreover, owing to unhealthy lifestyle there has been tremendous growth in the cardiovascular diseases which has led to the high usage of cardiovascular biomaterials. The materials mainly used in biomaterials are ceramics, metals, and polymers. Biomaterials possess diverse applications, some of which includes drug delivery, dental products, surgical appliances & supplies, general surgery, electromedical equipment and other applications. Browse the full "Biomaterials Market (Cardiovascular Biomaterials, Orthopedic Biomaterials, Wound Care Biomaterials, Urological Biomaterials Plastic Surgery Biomaterials and Gastrointestinal Biomaterials)  by Materials (Ceramics, Metals and Polymers) for Drug Delivery, Dental Products, Surgical Appliances & Supplies, General Surgery, Electromedical Equipment and Other Applications: Brazil Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022" report at https://www.zionmarketresearch.com/report/biomaterials-market There has been the sharp rise in the healthcare industry in Brazil owing to low healthcare cost. Brazil stands as the fifth largest country area wise and in population. The healthcare sector has undergone rapid transformation owing to the new business paradigm in Brazilian healthcare market. This factor is expected to trigger the growth of biomaterials market in this region in the upcoming years. An increasing number of life expectancy among the aging population may boost the biomaterials market in the forecast period. Moreover, Brazil is considered as the most favorable destination for medical tourism owing to its superior medical facilities, high-quality services, and low cost for treatment. This aspect is likely to bolster the growth of the biomaterial market. Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/biomaterials-market Allergan Inc., Artimplant Ab, Alphatec Spine Inc, Biomet Inc., Synthes Inc., Integra Life Sciences Holdings Corporation, Wright Medical Group, Inc., Stryker Corporation, Baxter International Inc. and Boston Scientific Corporation are some of the major players operating in the biomaterials market in Brazil. Due to various favorable government regulations many of the major companies are pulling towards Brazil. This report segments Brazil biomaterials market as follows: Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.


Svetlana M. Danovich, MD, PhD, Plastic Surgeon at SD Medical Arts, has been named a 2017 Top Doctor in Great Neck, New York. Top Doctor Awards is dedicated to selecting and honoring those healthcare practitioners who have demonstrated clinical excellence while delivering the highest standards of patient care. Dr. Svetlana M. Danovich is an experienced and respected plastic surgeon. Her medical career began in 2000, when she graduated from the Voronezh Medical Academy in Voronezh, Russia. Dr. Danovich then gained a Doctor of Philosophy Degree in Medical Chemistry and Biochemistry from the National University of Moscow. After moving to the United States, she completed an internship at the New York College of Osteopathic Medicine, followed by a residency at Stony Brook University. A fellowship in Cosmetic Surgery was then completed at the American Academy of Cosmetic Surgery in New York. Dr. Danovich is certified by the American Board of General Surgery, and is renowned as an expert in cosmetic surgery, carrying out a wide range of expert procedures. Procedures undertaken by her include liposuction, fat removal and fat transfer, breast augmentation and correction, tummy tucks, arm lifts, and face lifts. She is particularly renowned as an expert in minimally-invasive surgical techniques including vampire face lifts. Dr. Danovich now serves as the President and CEO of SD Medical Arts, where she is renowned not only for her clinical excellence but also for her caring and compassionate attitude and her winning bedside manner. A member of the sixth generation of physicians in her family, her dedication and expertise makes Dr. Svetlana M. Danovich a very worthy winner of a 2017 Top Doctor Award. Top Doctor Awards specializes in recognizing and commemorating the achievements of today’s most influential and respected doctors in medicine. Our selection process considers education, research contributions, patient reviews, and other quality measures to identify top doctors

Loading General Surgery collaborators
Loading General Surgery collaborators